Beigene, Ltd. (NASDAQ:ONC) COO Xiaobin Wu Sells 30,654 Shares

Beigene, Ltd. (NASDAQ:ONC) COO Xiaobin Wu sold 30,654 shares of the stock in a transaction on Tuesday, February 18th. The stock was sold at an average price of $240.74, for a total transaction of $7,379,643.96. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Xiaobin Wu also recently made the following trade(s):

• On Thursday, February 20th, Xiaobin Wu sold 21,267 shares of Beigene stock. The stock was sold at an average price of $240.07, for a total transaction of $5,105,568.69.

Beigene Stock Up 3.2 %

NASDAQ ONC opened at $244.20 on Friday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.72 and a current ratio of 1.93. Beigene, Ltd. has a 1 year low of $126.97 and a 1 year high of $248.16. The firm has a market cap of $23.90 billion, a price-to-earnings ratio of -29.64, a PEG ratio of 9.50 and a beta of 0.63.

Beigene Company Profile

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.